GENEVA, April 28 -- ANTEV LIMITED (Ibex House Baker StreetWeybridge KT13 8AH) filed a patent application (PCT/EP2024/079225) for "TEVERELIX-TFA IN A DOSAGE REGIME FOR USE IN THE TREATMENT OF PROSTATE CANCER" on Oct 16, 2024. With publication no. WO/2025/083070, the details related to the patent application was published on Apr 24, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): MACLEAN, Carol (Ibex House Baker StreetWeybridge KT13 8AH), VAN OS, Steve (Ibex House Baker StreetWeybridge KT13 8AH)
Abstract:
The present invention relates to a dosage regime for a teverelix-TFA composition used ...